Diversify Advisory Services LLC Purchases 4,245 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Diversify Advisory Services LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 58.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,472 shares of the medical equipment provider's stock after buying an additional 4,245 shares during the quarter. Diversify Advisory Services LLC's holdings in Intuitive Surgical were worth $5,907,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at approximately $250,000. Commerzbank Aktiengesellschaft FI raised its position in shares of Intuitive Surgical by 15.4% in the 1st quarter. Commerzbank Aktiengesellschaft FI now owns 11,131 shares of the medical equipment provider's stock valued at $5,513,000 after buying an additional 1,485 shares in the last quarter. Asset Advisors Investment Management LLC acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at approximately $1,707,000. Kingsview Wealth Management LLC raised its position in shares of Intuitive Surgical by 4.2% in the 1st quarter. Kingsview Wealth Management LLC now owns 4,535 shares of the medical equipment provider's stock valued at $2,246,000 after buying an additional 181 shares in the last quarter. Finally, Concord Wealth Partners raised its position in shares of Intuitive Surgical by 210.4% in the 1st quarter. Concord Wealth Partners now owns 3,390 shares of the medical equipment provider's stock valued at $1,679,000 after buying an additional 2,298 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have recently commented on ISRG. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Truist Financial lowered their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. BTIG Research set a $566.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average target price of $592.86.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the sale, the executive vice president owned 2,245 shares in the company, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,998 shares of company stock worth $2,611,577. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Up 0.5%

Shares of ISRG stock traded up $2.46 during trading hours on Friday, hitting $518.62. 1,903,997 shares of the company's stock were exchanged, compared to its average volume of 1,676,454. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The business's 50 day simple moving average is $535.90 and its 200-day simple moving average is $536.11. The company has a market capitalization of $185.88 billion, a PE ratio of 76.04, a PEG ratio of 5.47 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The business had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the business posted $1.50 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.